You just read:

Nonalcoholic Steatohepatitis (NASH) Therapeutics Market to Reach US$20.27 bn by 2025, Elafibranor Projected to Spur Growth: Transparency Market Research

News provided by

Transparency Market Research

18 Apr, 2016, 14:30 BST